Skip to main content
. Author manuscript; available in PMC: 2010 Jun 1.
Published in final edited form as: J Pharm Sci. 2009 Jun;98(6):2170–2179. doi: 10.1002/jps.21570

Table 2.

Displacement of [64Cu]Cu-ATSM and [64Cu]Cu-ETS from HSA by Drug Competition

% Free (corrected) ± SD (n ≥ 3)

[64Cu]Cu-ATSM [64Cu]Cu-ETS

Mole Ratio
(Drug:HSA)
Warfarin Ibuprofen Warfarin Ibuprofen
0 5.9 ± 0.4 5.9 ± 0.4 40.6 ± 1.1 40.6 ± 1.1
0.5 7.3 ± 0.2 7.1 ± 0.6 42.8 ± 1.6 43.9 ± 2.2
1 9.4 ± 0.8 7.5 ± 0.8 44.2 ± 1.2 42.1 ± 2.7
2 12.4 ± 0.9 8.2 ± 1.1 45.2 ± 1.3 45.8 ± 2.6
4 14.5 ± 0.6 7.3 ± 0.8 42.8 ± 3.4 43.6 ± 3.1
8 19.0 ± 1.7 10.5 ± 1.1 44.7 ± 2.7 49.6 ± 1.2